Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Selected Financial Data
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Income Statement

Medtronic PLC, selected items from income statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).


Net Sales
Net sales exhibit a consistent upward trajectory from 2005 through 2025, increasing from $10,055 million in 2005 to $33,537 million projected in 2025. This represents more than a threefold growth over two decades. The growth is steady with no significant declines; however, some years show more modest increases, such as between 2019 and 2020 where sales dipped slightly from $30,557 million to $28,913 million, likely due to external factors affecting the market. Following that year, sales rebounded consistently through to the 2025 projection.
Operating Profit
Operating profit data is available starting from 2013. It shows an initial figure of $4,402 million, followed by fluctuations over the subsequent years. There was a slight decline in 2014 and 2015, dropping to $3,766 million, then a notable increase to $5,291 million in 2016 and continuing to rise, reaching a peak of $6,651 million in 2018. After this peak, operating profit experienced volatility, with declines in 2019 and 2020 to around $4,484 million and $4,791 million respectively. From 2021 to the 2025 projection, operating profit improves again, reaching $5,955 million, indicating a recovery and positive momentum in operational efficiency or profitability despite interim fluctuations.
Net Income Attributable to Medtronic
Net income shows a mixed pattern over the full period from 2005 to 2025. Initial growth is visible from $1,804 million in 2005 up to $3,617 million in 2012. From 2013 onwards, net income fluctuates considerably. It reached a high of $4,631 million in 2018, closely followed by a decline in 2019 and 2020 to $3,104 million and $4,789 million respectively, reflecting variability possibly linked to operational challenges or external economic factors. From 2021 to 2025, net income again shows fluctuations but generally maintains a range between $3,600 million and $4,662 million, suggesting some recovery and stabilization but without a clear definitive upward trend as strong as observed for net sales.
Overall Observations
The company demonstrates strong sales growth over the long term, indicating successful market expansion or product acceptance. Operating profits, while somewhat volatile, generally maintain a healthy level with recovery phases after periodic declines, suggesting operational resilience. Net income reflects more variation, possibly impacted by non-operational factors such as financial expenses, taxes, or extraordinary items. The data indicates that while revenue generation remains robust, profitability metrics experience more fluctuations, pointing to possible shifts in cost structures, investment cycles, or external market conditions.

Balance Sheet: Assets

Medtronic PLC, selected items from assets, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).


The analysis of the annual financial data reveals several trends in the asset structure over the observed periods.

Current Assets
Current assets exhibit notable fluctuations throughout the years. Beginning at 7,422 million USD in 2005, there is an overall increasing trend with some variability. The values peak significantly at 30,844 million USD in 2014, indicating a considerable rise in short-term assets available during that period. After this peak, current assets decline sharply to 23,600 million USD in 2016 and then continue to fluctuate in a narrower range between approximately 21,675 million USD and 23,814 million USD towards 2025. The drop after 2014 suggests a change in working capital management or asset reallocation strategy.
Total Assets
Total assets show an upward trajectory from 16,617 million USD in 2005 to a substantial jump to 106,685 million USD in 2015. This dramatic increase between 2014 and 2015 is the most significant shift observed in the dataset, pointing to possible acquisitions, revaluation, or major capital investments. After reaching this peak, total assets slightly decline but remain near the 90,000 million USD level, with values between 89,681 million USD and 93,083 million USD through to 2025. This relative stabilization suggests a consolidation phase following rapid expansion.

Overall, the data indicates strong growth in both current and total assets over the 20-year span, with particularly pronounced asset base expansion around 2014-2015. The subsequent decline and stabilization in both asset categories may reflect strategic adjustments or market conditions impacting asset composition and scale. The contrast between the peak and later figures underscores shifts in asset management and possibly corporate structure or investment focus.


Balance Sheet: Liabilities and Stockholders’ Equity

Medtronic PLC, selected items from liabilities and stockholders’ equity, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).


The analysis of the financial data reveals several notable trends in the company's liabilities and shareholders’ equity over the period studied.

Current Liabilities
The current liabilities display considerable volatility with values fluctuating between approximately 2,563 million USD and 14,220 million USD. There is an overall upward trend, especially evident from around 2014 onwards, with peaks in 2015 and 2017. This volatility might indicate fluctuations in short-term obligations or operational cycles.
Total Liabilities
Total liabilities exhibit a generally increasing trend, growing from 6,168 million USD initially to peaking at above 53,455 million USD around 2015. Following this peak, a decline is observed with some stability around the 39,000-41,000 million USD range in later years. This suggests a period of significant liability accumulation followed by deleveraging or stabilization.
Total Debt
Total debt closely mirrors the pattern of total liabilities, showing marked growth culminating around 2015, where it exceeds 36,000 million USD. Subsequent years show a reduction and relative stability within the 24,000-28,000 million USD band. This indicates that the majority of liabilities are debt-related and that debt management may have been a focus following the peak.
Shareholders’ Equity
Shareholders’ equity has generally increased, moving from just over 10,450 million USD to levels exceeding 50,000 million USD by 2015. However, after this peak, equity values show a gradual decline and stabilization in the range of approximately 48,000 to 52,500 million USD. This pattern suggests growth over the long term but some pressure or adjustments impacting equity in recent years.
Overall Insights
The data reveals a significant expansion in both liabilities and shareholders’ equity up to the mid-2010s, pointing to possible company growth or acquisitions. The peak around 2015 across these metrics, followed by a partial reduction or stabilization, may reflect strategic financial restructuring, debt repayment, or changes in investment. The divergence between the fluctuations in current liabilities and the more gradual changes in total liabilities and equity indicates short-term operational variation amid longer-term strategic financial management.

Cash Flow Statement

Medtronic PLC, selected items from cash flow statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).


The analysis of the financial cash flow data over the period from 2005 to 2025 reveals several notable trends in operating, investing, and financing activities.

Operating Activities
The net cash provided by operating activities shows an overall upward trend with some fluctuations. Starting at $2,819 million in 2005, it experiences notable increases, reaching a high of $7,007 million in 2019. Thereafter, some variability is observed, with values oscillating between approximately $6,000 million and $7,300 million through 2024. The data indicates strong and generally growing operating cash flows, suggesting sustained core business cash generation capability over the period analyzed.
Investing Activities
Net cash used in investing activities predominantly reflects cash outflows, indicating ongoing investments. Significant negative values are present for most years, such as -$17,058 million in 2015, suggesting major capital expenditures or acquisitions during that period. There are occasional years with positive cash flow from investing (e.g., 2016 and 2018), which may signify divestitures or asset sales. However, the trend is largely characterized by substantial cash outflows, consistent with aggressive investment and asset acquisition strategies.
Financing Activities
The cash flows from financing activities exhibit considerable volatility. Initial years show both inflows and outflows, but beginning around 2011, pronounced outflows dominate, with large negative values from 2013 through 2025, such as -$11,954 million in 2018 and persistent negative outflows thereafter. This pattern may reflect debt repayments, share repurchases, dividend payments, or other cash uses related to financing. The exception is the sharp inflow of $15,949 million in 2015, which could indicate significant financing raised through debt or equity issuance. Overall, financing activities show a pattern of cash usage in the latter half of the period after occasional significant inflows earlier.

In summary, the company sustains strong operating cash flows with general growth over the two decades. It consistently invests heavily in its operations or acquisitions, typically reflected in negative investing cash flows. Financing activities are marked by volatility but trend toward cash outflows especially in recent years, possibly indicating deleveraging or capital return strategies. This combination suggests a focus on internal cash generation and investment while managing financing costs and liabilities over time.


Per Share Data

Medtronic PLC, selected data per share, long-term trends

US$

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

1, 2, 3 Data adjusted for splits and stock dividends.


The analysis of the financial data over the years reveals several notable trends in earnings per share (EPS) and dividends for the company.

Basic Earnings per Share (EPS)
Basic EPS exhibited a general upward trend from 2005 to 2012, increasing from 1.49 US$ in 2005 to a peak of 3.43 US$ in 2012. However, this was followed by fluctuations, with notable decreases in 2014 (3.06 US$) and 2015 (2.44 US$). After a partial recovery in 2016 and 2017, EPS again showed variability through 2019, reaching 3.44 US$. The period from 2020 to 2024 showed additional volatility with EPS oscillating between approximately 2.68 US$ and 3.75 US$, before a rise to 3.63 US$ in 2025. This pattern suggests cyclical influences or operational challenges affecting profitability.
Diluted Earnings per Share (EPS)
The trend in diluted EPS closely mirrors that of basic EPS, indicating consistent share dilution effects without large discrepancies. After an initial rise up to 2012, diluted EPS fluctuated in a pattern similar to the basic EPS, peaking at 3.73 US$ in 2023 and closing at 3.61 US$ in 2025. The similarity in movements between basic and diluted EPS suggests stable share issuance policies and consistent earnings quality.
Dividend per Share
Dividends per share showed a steady and almost continuous increase over the entire period. From 0.34 US$ in 2005, dividends grew gradually every year to reach 2.80 US$ in 2025. This upward trajectory reflects a consistent commitment to returning value to shareholders and suggests growth in cash flow and profitability sufficient to sustain increasing payouts. The dividend growth was particularly pronounced from 2012 onwards, with dividend hikes every year, regardless of the EPS fluctuations.

In summary, while earnings per share experienced significant fluctuations and periods of decline, dividends increased steadily, indicating a company strategy that prioritizes shareholder returns and may rely on stable cash generation, possibly supplemented by other financial measures. The divergence between fluctuating EPS and steadily rising dividends may be of interest for further investigation into earnings quality, cash flow stability, and capital allocation policies.